Evidence map›Paper›PMID 29429606›Full record

ArticleAmerican journal of preventive medicine2018

Challenges Implementing Lung Cancer Screening in Federally Qualified Health Centers.

Steven B Zeliadt, Richard M Hoffman, Genevieve Birkby, Jan M Eberth, Alison T Brenner, Daniel S Reuland, Susan A Flocke

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Trial
  2. Article
  3. Over- and underscreening for lung cancer.Translational lung cancer research · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. The Role of Federally Qualified Health Centers in Achieving Equitable Cancer Screening.Journal of the American College of Radiology : JACR · 2025
    Article
  9. Review
  10. Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Outcomes of Shared Decision-Making for Low-Dose Screening for Lung Cancer in an Academic Medical Center.Journal of cancer education : the official journal of the American Association for Cancer Education · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Steven B ZeliadtDepartment of Health Services, School of Public Health, University of Washington, Seattle, Washington; Center of Innovation for Veteran-Centered and Value-Driven Care, Veterans Health Administration, Seattle, Washington. Electronic address: szeliadt@uw.edu.
Richard M HoffmanDepartment of Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa; Holden Comprehensive Cancer Center, Iowa City, Iowa.
Genevieve BirkbyCenter for Community Health Integration and the Prevention Research Center for Healthy Neighborhoods, Case Western Reserve University, Cleveland, Ohio.
Jan M EberthDepartment of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina; Cancer Prevention and Control Program, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina.
Alison T BrennerLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
Daniel S ReulandDepartment of Medicine, Division of General Internal Medicine, University of North Carolina, Chapel Hill, North Carolina.
Susan A FlockeCenter for Community Health Integration and the Prevention Research Center for Healthy Neighborhoods, Case Western Reserve University, Cleveland, Ohio; Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio; Cancer Prevention, Control and Population Research, Case Comprehensive Cancer Center, Cleveland, Ohio.

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
ACL HHS U48DP005000ACL HHS U48DP005013ACL HHS U48DP005014ACL HHS U48DP005017ACL HHS U48DP005021ACL HHS U48DP005030NCCDPHP CDC HHS U48 DP001911NCCDPHP CDC HHS U48 DP005000NCCDPHP CDC HHS U48 DP005013NCCDPHP CDC HHS U48 DP005014NCCDPHP CDC HHS U48 DP005017NCCDPHP CDC HHS U48 DP005021NCCDPHP CDC HHS U48 DP005030
6 · The paper itself

Abstract

introductionThe purpose of this study is to identify issues faced by Federally Qualified Health Centers (FQHCs) in implementing lung cancer screening in low-resource settings.

methodsMedical directors of 258 FQHCs serving communities with tobacco use prevalence above the median of all 1,202 FQHCs nationally were sampled to participate in a web-based survey. Data were collected between August and October 2016. Data analysis was completed in June 2017.

resultsThere were 112 (43%) FQHC medical directors or surrogates who responded to the 2016 survey. Overall, 41% of respondents were aware of a lung cancer screening program within 30 miles of their system's largest clinic. Although 43% reported that some providers in their system offer screening, it was typically at a very low volume (less than ten/month). Although FQHCs are required to collect tobacco use data, only 13% indicated that these data can identify patients eligible for screening. Many FQHCs reported important patient financial barriers for screening, including lack of insurance (72%), preauthorization requirements (58%), and out-of-pocket cost burdens for follow-up procedures (73%). Only 51% indicated having adequate access to specialty providers to manage abnormal findings, and few reported that leadership had either committed resources to lung cancer screening (12%) or prioritized lung cancer screening (12%).

conclusionsFQHCs and other safety-net clinics, which predominantly serve low-socioeconomic populations with high proportions of smokers eligible for lung cancer screening, face significant economic and resource challenges to implementing lung cancer screening. Although these vulnerable patients are at increased risk for lung cancer, reducing patient financial burdens and appropriately managing abnormal findings are critical to ensure that offering screening does not inadvertently lead to harm and increase disparities.

Indexed as

AgedAmbulatory Care FacilitiesEarly Detection of CancerHealthcare DisparitiesHealth Care SurveysHealth ExpendituresHealth Plan ImplementationHealth ResourcesHumansLung NeoplasmsMass ScreeningMiddle AgedPhysician ExecutivesPovertySafety-net ProvidersSmokers

Identifiers

PMID29429606
PMCPMC8483158

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.